E RACHT: Open Payments
NPI 1811980790 · AUBURN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,655 in 114 payments from 19 companies in 2025. Trend: 2023 $1,195 · 2024 $1,195 · 2025 $2,655
Food & beverage: $2,655
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $518 |
| Janssen Biotech, Inc. | 10 | $399 |
| UCB, Inc. | 5 | $248 |
| LEO Pharma Inc. | 9 | $213 |
| Lilly USA, LLC | 10 | $202 |
| Galderma Laboratories, L.P. | 11 | $191 |
| PFIZER INC. | 8 | $159 |
| Novartis Pharmaceuticals Corporation | 7 | $155 |
| Stryker Corporation | 1 | $146 |
| Amgen Inc. | 2 | $68 |
Products named: TREMFYA, RINVOQ, Bimzelx, SKYRIZI, NEMLUVIO, CIBINQO, LIFEPAK 35, ADBRY.
Industry payments across MA — which companies pay providers there.
